Children’s National Stimulating Access to Research in Residency (CNStARR) Program (NHLBI)

儿童国家激励住院医师研究机会 (CNStARR) 计划 (NHLBI)

基本信息

  • 批准号:
    10593715
  • 负责人:
  • 金额:
    $ 42.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: Funded by one of the inaugural R38 awards from the National Heart, Lung, and Blood Institute (NHLBI), the Children’s National Stimulating Access to Research in Residency (CNStARR) Program is an existing mentored program of career development and research training. It has dramatically expanded our institution’s capacity to recruit and retain outstanding residents with demonstrated potential and interest in pursuing research careers in content areas of interest to the NHLBI with a special emphasis on asthma and airway diseases, congenital heart disease, and hematology and immunology. Each content area was chosen because of the depth and breadth of our locally available, committed, and highly experienced preceptors. Leveraging the existing collaborations between Children’s National Hospital (CNH) and George Washington University (GWU) such as their jointly held Clinical and Translational Science Institute, CNStARR will recruit residents in pediatrics from CNH and in internal medicine from GWU. Utilizing the existing infrastructure of the Children’s Hospital Research in Residency Program and as well as highly tailored and focused Individual Development Plans, CNStARR provides its scholars with both the didactic competencies and the transformative mentored experiences in basic, clinical, or translational research to prepare them as successful, independent clinician- scientists. The most proximate goal of CNStARR is to accelerate the transition of participants to subsequent mentored career development awards, particularly the “Stimulating Access to Research and Residency Transition Support,” the linked individual K38 mechanism from the National Institutes of Health, as well as other mechanisms such as T32 and F32 appointments, our institutional KL2 and K12 awards, or individual K- series awards. CNStARR scholars will join the future academic leaders in research areas of relevance to NHLBI. Ultimately, they will direct research teams, compete successfully for grant support, and add significantly to our understanding of the etiology and treatment of heart, lung, and blood disorders across the human life span. Because academic medicine in general (and pediatrics and internal medicine) suffers grievously from a shortage of investigators from backgrounds under-represented in medicine (UIM), CNStARR will pursue an intentional and deliberate strategy to identify, recruit, and retain scholars from backgrounds UIM.
项目概要/摘要: 由国家心脏,肺和血液研究所(NHLBI)的首届R38奖项之一资助, 儿童的国家刺激访问研究住院医师(CNStARR)计划是一个现有的指导 职业发展和研究培训计划。它极大地扩展了我们机构的能力, 招募和留住优秀的居民与表现出的潜力和兴趣,在追求研究事业 在NHLBI感兴趣的内容领域,特别强调哮喘和气道疾病,先天性 心脏病血液学和免疫学选择每个内容区域是因为其深度和 我们的本地可用的广度,承诺,和经验丰富的导师.利用现有的 儿童国立医院(CNH)和乔治华盛顿大学(GWU)之间的合作,如 他们联合举办的临床和转化科学研究所,CNStARR将招募儿科住院医师, CNH和GWU的内科。利用儿童医院现有的基础设施 研究居住计划,以及高度定制和集中的个人发展计划, CNStARR为学者提供了教学能力和变革指导 基础,临床或转化研究的经验,使他们成为成功的,独立的临床医生- 科学家CNStARR最接近的目标是加速参与者向后续阶段的过渡, 指导职业发展奖,特别是“刺激获得研究和居住 过渡支持”,美国国立卫生研究院的链接个人K38机制,以及 其他机制,如T32和F32任命,我们的机构KL 2和K12奖励,或个人K- 系列奖项。CNStARR学者将加入未来的学术领导人在相关的研究领域, NHLBI。最终,他们将指导研究团队,成功地竞争赠款支持,并增加 这对我们理解心脏、肺和血液疾病的病因和治疗有重要意义。 人类寿命。因为一般的学术医学(以及儿科和内科) 令人痛心的是,由于缺乏来自医学背景的研究人员(UIM),CNStARR 将追求一个故意和深思熟虑的战略,以确定,招聘,并保留来自背景UIM学者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN John TEACH其他文献

STEPHEN John TEACH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN John TEACH', 18)}}的其他基金

District of Columbia Childhood Asthma in Urban Settings - Clinical Research Center
哥伦比亚特区城市环境中的儿童哮喘 - 临床研究中心
  • 批准号:
    10210851
  • 财政年份:
    2021
  • 资助金额:
    $ 42.41万
  • 项目类别:
District of Columbia Childhood Asthma in Urban Settings - Clinical Research Center
哥伦比亚特区城市环境中的儿童哮喘 - 临床研究中心
  • 批准号:
    10393005
  • 财政年份:
    2021
  • 资助金额:
    $ 42.41万
  • 项目类别:
Asthma Care Implementation Program for the District of Columbia (ACIP-DC)
哥伦比亚特区哮喘护理实施计划 (ACIP-DC)
  • 批准号:
    9018607
  • 财政年份:
    2015
  • 资助金额:
    $ 42.41万
  • 项目类别:
PROSPECTIVE MULTICENTER STUDY OF BRONCHIOLITIS ADMISSIONS: ETIOLOGY AND DISPOSIN
细支气管炎入院的前瞻性多中心研究:病因和处置
  • 批准号:
    8167363
  • 财政年份:
    2010
  • 资助金额:
    $ 42.41万
  • 项目类别:
INNER-CITY ANTI-IGE THERAPY FOR ASTHMA (ICATA)
内城区哮喘抗 ​​IGE 治疗 (ICATA)
  • 批准号:
    8167297
  • 财政年份:
    2010
  • 资助金额:
    $ 42.41万
  • 项目类别:
INNER-CITY ANTI-IGE THERAPY FOR ASTHMA (ICATA)
内城区哮喘抗 ​​IGE 治疗 (ICATA)
  • 批准号:
    7951082
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:
PROSPECTIVE MULTICENTER STUDY OF BRONCHIOLITIS ADMISSIONS: ETIOLOGY AND DISPOSIN
细支气管炎入院的前瞻性多中心研究:病因和处置
  • 批准号:
    7951136
  • 财政年份:
    2008
  • 资助金额:
    $ 42.41万
  • 项目类别:
INNER-CITY ANTI-IGE THERAPY FOR ASTHMA (ICATA)
内城区哮喘抗 ​​IGE 治疗 (ICATA)
  • 批准号:
    7717146
  • 财政年份:
    2007
  • 资助金额:
    $ 42.41万
  • 项目类别:
INNER CITY ASTHMA CONSORTIUM, ASTHMA CONTROL EVALUATION (ACE)
内城哮喘协会,哮喘控制评估 (ACE)
  • 批准号:
    7717184
  • 财政年份:
    2007
  • 资助金额:
    $ 42.41万
  • 项目类别:
INNER CITY ASTHMA CONSORTIUM, ASTHMA CONTROL EVALUATION (ACE)
内城哮喘协会,哮喘控制评估 (ACE)
  • 批准号:
    7608371
  • 财政年份:
    2006
  • 资助金额:
    $ 42.41万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 42.41万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了